SomaLogic, Inc.

SomaLogic, Inc. (Nasdaq: SLGC) is a Boulder, Colorado-based proteomics company that completed a SPAC merger with CM Life Sciences III Inc. (Nasdaq: CMLF), sponsored by CM Life Sciences, in September 2021. The blank-check vehicle IPO'd earlier that year, targeting the life sciences and diagnostics sector. SomaLogic's proprietary SomaScan platform enables large-scale protein measurement for biomarker discovery, drug development, and clinical diagnostics. The company filed a Form 10-Q with the SEC on August 16, 2021, shortly before the business combination closed. In early 2024, SomaLogic merged with Standard BioTools Inc., and SLGC no longer trades as an independent public company. Sign up for SpacDesk to access the full filing history and deal timeline for this and thousands of other SPAC transactions.